Corporate Announcement
Security Code : 539871    Company : THYROCARE    
 
Board Meeting Intimation for Discussing The Offer Made By Dr.A. Velumani, Chairman, Managing Director & CEO, To Acquire The Shareholding Of The Company In Nueclear Healthcare Limited, The Wholly Owned Subsidiary Of The Company.Download PDFDownload XBRL
  Exchange Received Time  10/06/2019 19:02:20         Exchange Disseminated Time   10/06/2019 19:02:27              Time Taken   00:00:07
Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/06/2019 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors will be held on Thursday, June 13, 2019, to discuss about the offer made by Dr. A. Velumani, Chairman, Managing Director & CEO to acquire the shareholding of the Company in Nueclear Healthcare Limited (NHL), the wholly owned subsidiary of the Company.
 

Disclaimer

Back To Announcements